戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 after administration of hetastarch 35 mL/kg (hypervolemia).
2 belief that CHF is associated with long-term hypervolemia.
3 in 30% of KTRs, with 5% classified as severe hypervolemia.
4 is study were to establish the prevalence of hypervolemia among clinically stable KTRs, investigate t
5 scaling relation may indicate hypovolemia or hypervolemia and aid diagnosis.
6 and/or saline intake to prevent or attenuate hypervolemia and hypernatremia.
7 poxemia, hypercarbia, acidosis, hypothermia, hypervolemia, and increased intrathoracic pressure).
8 postural thoracic hypovolemia and splanchnic hypervolemia are associated with postural simple faint.
9 investigate the predictors of posttransplant hypervolemia, assess its impact on blood pressure, and d
10                                         With hypervolemia, cardiac output increased at low-level CPAP
11 xcessive thoracic hypovolemia and splanchnic hypervolemia during orthostasis compared with healthy su
12           The prevalence and consequences of hypervolemia in kidney transplant recipients (KTRs) have
13                            In the absence of hypervolemia, intravenous fluid delivery is frequently t
14 reased cardiac output with low-level CPAP in hypervolemia is associated with systemic vasodilation.
15   Close monitoring of fluid balance to avoid hypervolemia is essential.
16                                              Hypervolemia is unexpectedly common among clinically sta
17 vels were independently associated with both hypervolemia (P=0.01) and allograft dysfunction (P=0.03)
18                                              Hypervolemia was present in 30% of KTRs, with 5% classif
19                                              Hypervolemia was the only independent predictor of eleva
20                              Mild and severe hypervolemia were defined as percentage volume expansion
21 ts hospitalized for HF with > or =2 signs of hypervolemia were randomized to ultrafiltration or intra
22 entration in patients who have euvolemia and hypervolemia with hyponatremia in the short term (</=30

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。